GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $36.78 $42.85 Monday, 22nd Apr 2024 CLDX stock ended at $38.85. This is 2.29% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 3.71% from a day low at $37.99 to a day high of $39.40.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Mar 15, 2024 $42.23 $42.94 $41.67 $42.01 1 849 073
Mar 14, 2024 $45.05 $45.05 $41.60 $42.52 896 829
Mar 13, 2024 $46.10 $47.50 $45.17 $45.32 883 082
Mar 12, 2024 $46.41 $47.04 $45.33 $46.05 715 860
Mar 11, 2024 $47.50 $48.37 $46.44 $46.54 666 758
Mar 08, 2024 $47.68 $49.65 $47.28 $47.91 872 764
Mar 07, 2024 $48.57 $49.06 $46.84 $46.96 716 873
Mar 06, 2024 $49.58 $50.64 $48.09 $48.55 1 680 995
Mar 05, 2024 $50.23 $50.71 $48.97 $50.01 2 136 108
Mar 04, 2024 $53.10 $53.18 $49.48 $50.71 1 738 800
Mar 01, 2024 $47.91 $52.99 $47.69 $51.88 3 148 241
Feb 29, 2024 $51.50 $51.71 $46.82 $48.06 1 201 789
Feb 28, 2024 $51.80 $52.95 $50.66 $51.37 991 057
Feb 27, 2024 $49.13 $51.64 $48.81 $51.04 1 880 936
Feb 26, 2024 $39.22 $48.94 $38.96 $48.23 4 756 503
Feb 23, 2024 $37.55 $39.08 $36.60 $37.75 1 181 202
Feb 22, 2024 $38.36 $38.36 $37.08 $37.44 380 646
Feb 21, 2024 $38.36 $39.13 $37.41 $37.72 441 669
Feb 20, 2024 $37.94 $39.09 $37.94 $38.50 576 913
Feb 16, 2024 $36.65 $38.58 $36.18 $38.25 1 180 409
Feb 15, 2024 $36.50 $37.09 $35.65 $36.80 784 406
Feb 14, 2024 $35.85 $36.61 $35.36 $36.26 779 883
Feb 13, 2024 $35.98 $36.09 $35.03 $35.27 532 641
Feb 12, 2024 $38.04 $38.53 $37.56 $37.59 491 800
Feb 09, 2024 $37.75 $38.28 $37.22 $38.04 481 575
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

^ false

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT